MSN Money | 5 hours ago
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today the details relating to its second quarter 2010 results...
ABC News | 7 hours ago
Can you put a price tag on the life of a prostate cancer patient? . . With the advent of Provenge, the first-ever vaccine cancer treatment, that...
Wausau Daily Herald, Wisconsin | 9 hours ago
If you were out in the Weston industrial park around lunch time Wednesday, you might have thought the roads had turned into a race course.. . ....
Medical News Today | 9 hours ago
Dendreon Corporation (Nasdaq: DNDN) announced the publication of data from the pivotal Phase 3 IMPACT study in the New England Journal of Medicine...
HealthScout.com | 9 hours ago
A newly approved therapeutic prostate cancer vaccine extended the lives of men with metastatic tumors resistant to standard hormonal treatment, a ...
